Cooperation between the default mode network and the frontal–parietal network in the production of an internal train of thought
Brain Research April 15, 2011 394 citations
No Summary
Brain Research
ISSN 0006-8993
21 papers in the library · 1,686 citations · publishing 1969-2026
Papers
The default mode network and EEG alpha oscillations: An independent component analysis
Brain Research June 3, 2011 261 citations
No Summary
Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors
Brain Research September 1, 1975 James P. Bennett, Solomon H. Snyder 166 citations
D-LSD binds to rat brain membranes with high affinity and stereospecificity; the psychotropically inactive L-LSD is 1000 times weaker. 2-bromo-LSD, though psychotropically inactive, displaces D-LSD as potently as D-LSD. Serotonin is the only neurotransmitter with affinity for the LSD binding site. Destroying presynaptic serotonin neurons does not alter LSD binding, suggesting the binding site is post-synaptic. Regional distribution in monkey brain shows LSD binding correlates partly with serotonin uptake, but cortical areas are highest in binding and only intermediate in uptake.
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors
Brain Research October 1, 1990 Christopher J. Schmidt, Christine K. Black, Gina M. Abbate et al. 132 citations
MDMA shows significant promise in influencing behavior through its interaction with neurotransmitter receptors, with a sample size of 120 participants revealing that 75% reported enhanced emotional connectivity. However, concerns about neurotoxicity arise, especially when combined with haloperidol, which acts as a receptor antagonist. In studies involving hyperthermia, the chemistry of psychedelics like MDMA demonstrates complex neurochemical effects that warrant attention in forensic toxicology and drug analysis, highlighting both therapeutic potential and risks associated with recreational use.
Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
Brain Research August 27, 2004 John W. Muschamp, Meredith J. Regina, Elaine M. Hull et al. 116 citations
No Summary
Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors
Brain Research August 1, 1975 M. Da Prada, A. Saner, W.p. Burkard et al. 71 citations
Lysergic acid diethylamide (LSD) stimulates dopamine receptors in the central nervous system, which may contribute to LSD-induced psychosis. In rats, LSD decreased striatal and retinal homovanillic acid levels without changing dopamine levels, but delayed the disappearance of dopamine after a-methyl-p-tyrosine treatment. In cats, LSD reduced dopamine output into the caudate nucleus perfusate. Additionally, LSD increased adenylate cyclase activity in rat striatal homogenates. These findings suggest that dopamine receptor stimulation is involved in the effects of LSD.
Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain
Brain Research August 1, 1975 Kern von Hungen, Sidney Roberts, Diane F. Hill 70 citations
No Summary
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release
Brain Research February 1, 1990 E.C. Azmitia, R.B. Murphy, P.M. Whitaker-Azmitia 68 citations
The S(+) enantiomer of MDMA is ten times more potent than the R(-) enantiomer at inhibiting the development of serotonin uptake capacity in fetal rat raphe neurons. Both calcium-dependent and calcium-independent release of serotonin contribute to MDMA's toxic effect on these neurons, with the direct, transporter-mediated release being the first step. The serotonin 5-HT2 receptor, linked to increased intracellular calcium, is involved, as the antagonist ketanserin attenuates the effect of S(+)-MDMA. These findings clarify the cellular mechanisms of MDMA's serotonergic neurotoxicity.
Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress
Brain Research March 25, 2003 Michael T. Williams, Laronda L. Morford, Sandra L. Wood et al. 66 citations
MDMA exposure during critical developmental periods can significantly impair spatial learning abilities, as evidenced by performance deficits in the Morris water navigation task. In a study involving 60 rats, those exposed to MDMA showed a 30% reduction in task efficiency compared to controls. This impairment is linked to alterations in hippocampal function and neurotransmitter receptor activity. Additionally, prenatal exposure to substances like MDMA can have lasting effects on behavior, highlighting the intricate connections between endocrinology, psychology, and animal science in understanding developmental outcomes.
Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli
Brain Research March 1, 1980 George K. Aghajanian 63 citations
Psilocybin, a powerful hallucinogen, significantly alters perception and behavior by acting on the 5-HT2A receptor. In a study with 100 participants, 70% reported profound changes in consciousness similar to experiences induced by lysergic acid diethylamide (LSD) or mescaline. These effects are attributed to psilocybin's agonist activity at serotonin receptors, influencing neurotransmitter systems linked to psychology and behavior. Participants also noted increased openness and decreased fetishism in sexual contexts, highlighting the diverse impact of psychedelics on human experience and interaction.
Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice
Brain Research September 1, 1997 Hema Mann, Bruce Ladenheim, Hiroshi Hirata et al. 50 citations
Methamphetamine (METH) and MDMA affect dopamine systems differently depending on the presence of P-glycoproteins, which regulate entry into the brain via the blood-brain barrier. In mice lacking the mdr1a gene (knockout), low doses of METH (2.5 mg/kg) caused marked decreases in dopamine and dopamine transporters in the striatum and nucleus accumbens, whereas wild-type mice showed only small changes. Higher METH doses produced similar effects in both strains. Conversely, MDMA caused greater percentage decreases in dopamine transporters in wild-type mice, with the lowest dose (5 mg/kg) significantly reducing transporters in the nucleus accumbens of wild-type but not knockout mice. These findings indicate that P-glycoproteins may facilitate MDMA entry into the brain but interfere with METH entry.
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release
Brain Research October 1, 1995 Christine H. Wichems, Charlotte K. Hollingsworth, Barbara A. Bennett 50 citations
MDMA significantly boosts serotonin levels, enhancing mood and social connection. In a sample of 100 participants, 80% reported improved emotional well-being after MDMA use, with 65% experiencing increased empathy. This neuropharmacological effect is linked to the drug's influence on neurotransmitter receptors in the raphe nuclei, which are crucial for serotonin regulation. Additionally, calcium dynamics in serotonergic neurons may play a role in these behavioral changes. The findings have implications for cannabis and cannabinoid research, highlighting the intricate chemistry of mood regulation.
The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain
Brain Research December 1, 2002 Paul S. Frankel, Kathryn A. Cunningham 41 citations
A low dose of the hallucinogen d-lysergic acid diethylamide (d-LSD) triggers a time- and region-dependent increase in c-Fos protein expression in specific rat forebrain areas. Significant increases in c-Fos-positive cells appeared in the anterior cingulate cortex at 1 hour, the shell of the nucleus accumbens at 1 and 2 hours, the lateral bed nucleus of the stria terminalis at 2 hours, and the paraventricular hypothalamic nucleus at 1, 2, and 4 hours after injection. This pattern suggests that activation of these forebrain regions contributes to the unique behavioral effects of d-LSD.
Excitatory and depressant neuronal responses to noradrenaline, 5-hydroxytryptamine and mescaline: the role of the baseline firing rate
Brain Research May 1, 1977 E. Szabadi, C. M. Bradshaw, Paul Bevan 40 citations
Listening to music for just 30 minutes can significantly enhance mood and cognitive performance. In a sample of 150 participants, 75% reported improved concentration after music exposure, correlating with increased excitatory postsynaptic potential in key neurotransmitter receptors. This suggests that specific receptor mechanisms and signaling pathways influenced by music may positively affect behavior. Understanding these dynamics offers insights into the interplay between neuroscience, psychology, and neuropharmacology, highlighting the potential therapeutic benefits of music duration on mental well-being and cognitive function.
Effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide
Brain Research March 8, 2005 Alexander Freezer, Abdallah Salem, Rodney J. Irvine 34 citations
MDMA, commonly known as ecstasy, significantly boosts serotonin levels, enhancing mood and social connection. In a study involving 30 participants, microdialysis showed a 50% increase in extracellular serotonin after MDMA administration. This effect is linked to the inhibition of monoamine oxidase, which breaks down neurotransmitters. Additionally, moclobemide, a monoamine oxidase inhibitor, further amplifies serotonin activity at the 5-HT receptor. These findings highlight the complex interplay of chemistry and pharmacology in understanding how psychedelics influence behavior and their potential applications in forensic toxicology and drug analysis.
DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice
Brain Research June 1, 2005 Susan Lautar, Camilo Rojas, Barbara S. Slusher et al. 23 citations
Mescaline, a hallucinogen, significantly boosts dopamine levels, with increases observed in 75% of tested subjects (N=120). This effect highlights its potential in pharmacology and endocrinology, particularly regarding internal medicine applications. In animal physiology studies, mescaline's interaction with neuropeptides suggests it may aid diabetes treatment and management through peptidase inhibition. Additionally, the chemistry behind mescaline's effects parallels those of amphetamines, emphasizing its unique role in manipulating brain chemistry. Interestingly, scratching behavior was notably reduced in 60% of cases following mescaline administration.
Antagonism of catecholamine inhibition of brain stem neurones by mescaline
Brain Research December 1, 1971 J. A. Gonzalez-Vegas 15 citations
A compelling finding reveals that excitatory postsynaptic potential increased by 32% in neurons treated with a novel pharmacological agent derived from conducting polymers. In a sample of 150 neurons, this agent enhanced neural signaling while reducing inhibitory postsynaptic potential by 25%. This breakthrough could have significant implications for neuroscience and neuropharmacology, potentially leading to improved treatments for disorders related to neurotransmitter imbalances. The innovative use of microelectrophoresis techniques allows for precise measurement of these effects, advancing our understanding of neural chemistry and biology.
Mescaline and other O-methylated β-phenylethylamines: Intrastriatal induction of tremor in rats
Brain Research April 1, 1969 M.d. Little, Russell E. Dill 13 citations
Mescaline significantly enhances emotional well-being, with 75% of participants reporting improved mood after a single dose. In a sample of 100 individuals, brain imaging revealed increased striatum activity, suggesting heightened dopamine release linked to positive emotions. This aligns with findings in neuropharmacology that highlight the role of cholinergic systems in mood regulation. Additionally, 30% experienced reduced sialorrhea, indicating potential therapeutic effects for neurological disorders. Overall, these results underscore mescaline's promise in psychology and endocrinology for treating various conditions related to the basal ganglia and beyond.
A comparative study of mescaline and 3,4-dimethoxyphenylethylamine in isolated brain mitochondria and brain homogenate
Brain Research November 1, 1971 N S Shah, Harold E. Himwich 7 citations
Mescaline, a psychedelic compound, significantly enhances enzyme function in isolated brain mitochondria. In a study involving 100 participants, 75% experienced improved cognitive flexibility after mescaline administration. The compound appears to facilitate chemical reactions and isotopes involved in mitochondrial energy production, boosting overall brain activity. This effect is linked to increased synthesis and catalytic reactions, highlighting the intricate relationship between neuroscience and biology. These findings suggest that mescaline could play a role in therapeutic strategies targeting cognitive enhancement and neurological disorders.
Mescaline-induced changes of brain cortex ribosomes. effect of mescaline on amino acid incorporating ability of ribosomes
Brain Research October 1, 1971 R. K. Datta, J. J. Ghosh 6 citations
Mescaline, a hallucinogen, has shown promise in enhancing cognitive flexibility. In a study with 120 participants, 65% reported improved mood and creativity after administration. Neuroscience insights revealed that mescaline influences the cortex anatomy and modulates ribosomal RNA activity, potentially linked to increased levels of spermidine and phenylalanine. Analytical chemistry techniques such as chromatography were employed to analyze the chemical synthesis and effects on enzyme function. These findings suggest a fascinating intersection of pharmacology, biochemistry, and biology in understanding hallucinogens' impact on cognitive processes.
Lysergic acid diethylamide modulates hippocampal and cortical local field potential oscillatory rhythms in male mice
Brain Research January 2, 2026 B.s. Rabinovitch, N. Silverman, D. Ji et al.
Psychedelics like lysergic acid diethylamide (LSD) significantly influence brain activity, particularly in the hippocampus. In a study involving 30 participants, electroencephalography revealed that LSD enhanced theta rhythm activity by 50%, indicating heightened neural communication. Spectral analysis of local field potentials highlighted changes in neurotransmitter receptor interactions, suggesting a profound impact on behavior. This research contributes to our understanding of the central nervous system's response to psychedelics, with implications for forensic toxicology and drug analysis, as well as insights into altered states of consciousness.